🇺🇸 FDA
Patent

US 7595326

Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs

granted A61KA61K31/38A61K31/404

Quick answer

US patent 7595326 (Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (BPU) sulfur analogs) held by Champions Biotechnology, Inc expires Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Champions Biotechnology, Inc
Grant date
Tue Sep 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/38, A61K31/404, A61K31/4152, A61K31/427